Genentech and Human Longevity Inc. announce multi-year agreement

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

GENENTECH and Human Longevity Inc. signed a multi-year agreement to conduct whole genome sequencing of tens of thousands of de-identified samples provided by Genentech, a member of the Roche Group.

HLI will sequence genomes to 30x coverage and analyze the data. Financial details of the agreement were not disclosed.

HLI is building a comprehensive integrated human genotype and phenotype database, the HLI Knowledgebase, using Illumina’s HiSeq X Ten and HiSeq 2500 sequencing machines and Pac Bio RS II instruments.

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login